Lebovits Chaim's Form 4 filing
Brainstorm Cell Therapeutics Inc. (BCLI) · filed Apr 25, 2024
- Accession no.
- 0001104659-24-051948
- Filed
- Apr 25, 2024
- Trade date
- Apr 19, 2024
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. It was filed 6 days after the trade, past the 2-business-day deadline.
This filing was later replaced by the amendment 0001104659-24-084336 (Jul 31, 2024). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lebovits ChaimCIK 0001406302 | Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 19, 2024 | Common Stock | AGrant or awardAcquired | +15,000 | $0.52 | +$7,800 | 858,565 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.